A2DMQY Cronos Group Inc

Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada

Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada

TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is expanding its portfolio for its Lord Jones® brand with new innovations to bolster its lineup of premium cannabis products in the Canadian market. The additions include new cultivars for the Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes, which are now available across Canada.

Since the brand’s launch in Canada in November 2023, Ice Water Hash Fusions Pre-Rolls have become the best-selling hash-infused pre-rolls in the country1. Curated with flower and terpene-rich ice water hash and fitted with a branded ceramic tip designed to cool the smoke, these 1g pre-rolls provide an elevated experience. The brand’s live resin vapes are designed to deliver a premium and highly potent vape experience at 70%+ THC in each all-in-one device and 510-cartridge. As of July 2024, the Lord Jones® brand has become the third best-selling live resin vape brand in Canada1.

The Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes are now available in the following new flavors and sizes:

Lord Jones® Ice Water Hash Fusions Pre-Rolls:

  • Sour Blueberry x Sour Blueberry
    • 1g ice water hash flower pre-roll with blueberry and gas flavor notes.
    • Indica | THC: 35-41% | 1x1g
  • Snow Lotus x Animal Mints
    • 1g ice water hash flower pre-roll with sweet, minty, and spicy flavor notes.
    • Hybrid | THC: 35-41% | 1x1g

Lord Jones® Live Resin Vapes (All-in-One and 510-Cartridge):

  • Gorilla Z Live Resin Vape
    • A flavor-forward vape designed to boast an elevated berry, cherry, and grape flavor experience.
    • Hybrid | 70+% THC
    • Available in two hardware options that are optimized for live resin usage:
      • A sleek 0.5g all-in-one device
      • A high-quality 1g 510-thread cartridge

“These new additions to our growing portfolio of Lord Jones® innovations demonstrate our commitment to delivering exceptional and truly differentiated products to the Canadian market,” said Mike Gorenstein, Chairman, President and CEO, Cronos. “We are thrilled by the enthusiastic response to the Lord Jones® brand after nearly one year in Canada, and we’re excited to launch future innovations that will introduce adult consumers to new and unique ways to experience and enjoy cannabis.”

To learn more about Lord Jones® products, visit us online at , and follow us on Instagram at .

1 Hifyre POS Data – July 2024





About Cronos Group Inc.

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements 

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about new and future product launches; product innovation; the consumer experience with respect to new and future product launches and innovations; and Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and the Company’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024, each of which has been filed on SEDAR+ and EDGAR and can be accessed at and /edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

For further information, please contact: 

Media Relations Contact: 

Emily Whalen 

Communications 

Tel: (416) 504-0004 

Investor Relations Contact:

Shayne Laidlaw 

Investor Relations 

Tel: (416) 504-0004 

Photos accompanying this announcement are available at



EN
28/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos Grows its International Footprint in Switzerland

Cronos Grows its International Footprint in Switzerland TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training. “We are excited to partner with Dascoli to bring high-quality medical cannabis to Swiss patients,” said Mike Gorenstein, Chairman, ...

 PRESS RELEASE

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Sharehol...

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was...

 PRESS RELEASE

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Co...

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST. A live webcast will be available on the Investors section of the Company’s website at . About Cronos Group Inc.Cronos is an innovative global cannabinoid company...

 PRESS RELEASE

Cronos Group Reports 2025 First Quarter Results

Cronos Group Reports 2025 First Quarter Results Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Industry-leading balance sheet with $838 million in total cash and cash equivalents and short-term investments TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 first quarter business results. "2025 is shaping up to be a transformative yea...

 PRESS RELEASE

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2025 Annual Meeting online regardless of their geographic location, including a chance to ask questions and vote. Th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch